Literature DB >> 23007624

Oxytocin: a therapeutic target for mental disorders.

Mitsuhiro Matsuzaki1, Hiroaki Matsushita, Kazuhito Tomizawa, Hideki Matsui.   

Abstract

We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood-brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007624     DOI: 10.1007/s12576-012-0232-9

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  40 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.

Authors:  Toshio Munesue; Shigeru Yokoyama; Kazuhiko Nakamura; Ayyappan Anitha; Kazuo Yamada; Kenshi Hayashi; Tomoya Asaka; Hong-Xiang Liu; Duo Jin; Keita Koizumi; Mohammad Saharul Islam; Jian-Jun Huang; Wen-Jie Ma; Uh-Hyun Kim; Sun-Jun Kim; Keunwan Park; Dongsup Kim; Mitsuru Kikuchi; Yasuki Ono; Hideo Nakatani; Shiro Suda; Taishi Miyachi; Hirokazu Hirai; Alla Salmina; Yu A Pichugina; Andrei A Soumarokov; Nori Takei; Norio Mori; Masatsugu Tsujii; Toshiro Sugiyama; Kunimasa Yagi; Masakazu Yamagishi; Tsukasa Sasaki; Hidenori Yamasue; Nobumasa Kato; Ryota Hashimoto; Masako Taniike; Yutaka Hayashi; Junichiro Hamada; Shioto Suzuki; Akishi Ooi; Mami Noda; Yuko Kamiyama; Mizuho A Kido; Olga Lopatina; Minako Hashii; Sarwat Amina; Fabio Malavasi; Eric J Huang; Jiasheng Zhang; Nobuaki Shimizu; Takeo Yoshikawa; Akihiro Matsushima; Yoshio Minabe; Haruhiro Higashida
Journal:  Neurosci Res       Date:  2010-05-01       Impact factor: 3.304

3.  Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test.

Authors:  Stella Chaviaras; Plato Mak; David Ralph; Lalitha Krishnan; Jillian H Broadbear
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

4.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

Authors:  A L Montejo; G Llorca; J A Izquierdo; F Rico-Villademoros
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

5.  RGS2 mediates the anxiolytic effect of oxytocin.

Authors:  Naoki Okimoto; Oliver J Bosch; David A Slattery; Konstanze Pflaum; Hiroaki Matsushita; Fan-Yan Wei; Masayasu Ohmori; Tei-ichi Nishiki; Iori Ohmori; Yuji Hiramatsu; Hideki Matsui; Inga D Neumann; Kazuhito Tomizawa
Journal:  Brain Res       Date:  2012-03-13       Impact factor: 3.252

6.  Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls.

Authors:  Renee J Thompson; Karen J Parker; Joachim F Hallmayer; Christian E Waugh; Ian H Gotlib
Journal:  Psychoneuroendocrinology       Date:  2010-08-14       Impact factor: 4.905

7.  Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade.

Authors:  Kazuhito Tomizawa; Norichika Iga; Yun-Fei Lu; Akiyoshi Moriwaki; Masayuki Matsushita; Sheng-Tian Li; Osamu Miyamoto; Toshifumi Itano; Hideki Matsui
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

8.  Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2010-10-13       Impact factor: 4.939

9.  Role of neuropeptides in antidepressant and memory improving effects of venlafaxine.

Authors:  Elzbieta Nowakowska; Krzysztof Kus; Teresa Bobkiewicz-Kozłowska; Hanka Hertmanowska
Journal:  Pol J Pharmacol       Date:  2002 Nov-Dec

10.  Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression.

Authors:  Shannon L Gourley; Florence J Wu; Drew D Kiraly; Jonathan E Ploski; Alexia T Kedves; Ronald S Duman; Jane R Taylor
Journal:  Biol Psychiatry       Date:  2007-09-24       Impact factor: 13.382

View more
  20 in total

Review 1.  Animal models of resistance exercise and their application to neuroscience research.

Authors:  Justin C Strickland; Mark A Smith
Journal:  J Neurosci Methods       Date:  2016-08-04       Impact factor: 2.390

2.  Intranasal administration of oxytocin increases compassion toward women.

Authors:  Sharon Palgi; Ehud Klein; Simone G Shamay-Tsoory
Journal:  Soc Cogn Affect Neurosci       Date:  2014-04-07       Impact factor: 3.436

3.  Effects of social deprivation on social and depressive-like behaviors and the numbers of oxytocin expressing neurons in rats.

Authors:  Yaminah D Gilles; Eva K Polston
Journal:  Behav Brain Res       Date:  2017-04-01       Impact factor: 3.332

4.  The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV.

Authors:  Destin D Shortell; Leah H Rubin; Aidan J Murphy; Ronald A Cohen; Eric C Porges
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

5.  Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats.

Authors:  Ammar Imad Hazim; Surash Ramanathan; Suhanya Parthasarathy; Mustapha Muzaimi; Sharif Mahsufi Mansor
Journal:  J Physiol Sci       Date:  2014-01-25       Impact factor: 2.781

6.  Four decades of research on alexithymia: moving toward clinical applications.

Authors:  Dalya Samur; Mattie Tops; Caroline Schlinkert; Markus Quirin; Pim Cuijpers; Sander L Koole
Journal:  Front Psychol       Date:  2013-11-19

7.  "Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes.

Authors:  Enrique J Cobos; Enrique Portillo-Salido
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

8.  Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways.

Authors:  Mei-Lyn Ong; Joanna Dawn Holbrook
Journal:  Aging Cell       Date:  2013-10-22       Impact factor: 9.304

9.  Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls.

Authors:  Eli Iacob; Kathleen C Light; Scott C Tadler; Howard R Weeks; Andrea T White; Ronald W Hughen; Timothy A Vanhaitsma; Lowry Bushnell; Alan R Light
Journal:  BMC Psychiatry       Date:  2013-10-21       Impact factor: 3.630

10.  Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children.

Authors:  Haidar A Abdulamir; Omar F Abdul-Rasheed; Emad A Abdulghani
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.